QuickView for Anoctamin-10 (biogroup)

1. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
2. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
3. Left cardiac ventricles of C57Bl/6J and C57Bl/6N males after angiotensin II infusion
4. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with ligand perturbagens
5. Brains, hearts and kidneys treated with angiotensin II

There were no matches for Anoctamin-10

1. MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants
2. 3 Year Follow up on ANO5 Patients
3. SSG XXV: The Stop-GIST Trial; Discontinuation of Imatinib in Patients With Oligo-metastatic GIST
4. Congenital Muscle Disease Study of Patient and Family Reported Medical Information
5. β-cell Function and Insulin Sensitivity in Patients With Cystic Fibrosis